JBSS Stock Analysis: John Sanfilippo & Son | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 886m USD | 12M Return: 17.7% | US8004221078 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.5M
EPS Trend: 72.6%
Qual. Beats: -1
Rev. Trend: 94.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) is a U.S.-based processor and distributor of tree nuts and peanuts, operating primarily through its subsidiary JBSS Ventures, LLC. The company offers an extensive product portfolio that includes raw and processed nuts (almonds, pecans, peanuts, walnuts, cashews, pistachios, and others), nutrition and snack bars, peanut butter, dried fruit, snack mixes, and toppings for ice cream and yogurt, among other items. JBSS markets its products under proprietary brands such as Fisher, Orchard Valley Harvest, Squirrel Brand, Southern Style Nuts, and Just the Cheese, as well as under various private-label brands. Its customer base spans retailers, wholesalers, and commercial ingredient and contract packaging clients, served through independent brokers, distributors, and suppliers. Founded in 1922 and headquartered in Elgin, Illinois, the company is publicly traded on NASDAQ and operates within the Consumer Staples sectors Packaged Foods & Meats sub-industry. As a packaged foods producer, JBSS benefits from the typically defensive characteristics of the consumer staples sector, with demand that tends to be relatively stable through economic cycles, and it generates revenue through both branded consumer products and B2B ingredient and contract packaging services.
- Tree nut commodity prices pressure product gross margins
- Private label nut sales expand with key retailer partnerships
- Fisher and Orchard Valley Harvest branded revenue grows
| Net Income: 61.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 8.80 > 1.0 |
| NWC/Revenue: 15.43% < 20% (prev 17.19%; Δ -1.77% < -1%) |
| CFO/TA 0.19 > 3% & CFO 123.8m > Net Income 61.9m |
| Net Debt (130.1m) to EBITDA (118.7m): 1.10 < 3 |
| Current Ratio: 2.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.8m) vs 12m ago 0.36% < -2% |
| Gross Margin: 17.96% > 18% (prev 18.38%; Δ -0.41% > 0.5%) |
| Asset Turnover: 187.2% > 50% (prev 185.3%; Δ 1.90% > 0%) |
| Interest Coverage Ratio: 35.16 > 6 (EBIT TTM 85.4m / Interest Expense TTM 2.43m) |
| A: 0.28 (Total Current Assets 349.3m - Total Current Liabilities 167.9m) / Total Assets 658.6m |
| B: 0.36 (Retained Earnings 236.7m / Total Assets 658.6m) |
| C: 0.14 (EBIT TTM 85.4m / Avg Total Assets 628.1m) |
| D: 1.36 (Book Value of Equity 379.9m / Total Liabilities 278.6m) |
| Altman-Z'' = 5.32 = AAA |
| DSRI: 1.04 (Receivables 84.5m/76.8m, Revenue 1.18b/1.11b) |
| GMI: 1.02 (GM 18.38% / 17.96%) |
| AQI: 0.71 (AQ_t 0.09 / AQ_t-1 0.12) |
| SGI: 1.06 (Revenue 1.18b / 1.11b) |
| TATA: -0.09 (NI 61.9m - CFO 123.8m) / TA 658.6m) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of August 28, 2026, the stock is trading at USD 73.99 with a total of 223,050 shares traded. Over the past week, the price has changed by -2.34%, over one month by -10.56%, over three months by -3.45% and over the past year by +17.72%.
Current recommended Stop Loss: 70.30 (which is 5% or 1.2 ATR below the current price).
John Sanfilippo & Son has no consensus analysts rating.
| Analysts Target Price | 102 | 37.9% |
P/E Trailing = 13.268
P/E Forward = 12.3001
P/S = 0.7606
P/B = 2.4831
P/EG = 1.5178
Revenue TTM = 1.18b USD
EBIT TTM = 85.4m USD
EBITDA TTM = 118.7m USD
Long Term Debt = 43.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = 45.1m USD (from shortTermDebt, last quarter)
Debt = 131.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 21.9m
Net Debt = 130.1m USD (calculated: Debt 131.3m - CCE 1.15m)
Enterprise Value = 1.02b USD (885.6m + Debt 131.3m - CCE 1.15m)
Interest Coverage Ratio = 35.16 (Ebit TTM 85.4m / Interest Expense TTM 2.43m)
EV/FCF = 28.41x (Enterprise Value 1.02b / FCF TTM 35.7m)
FCF Yield = 3.52% (FCF TTM 35.7m / Enterprise Value 1.02b)
FCF Margin = 3.04% (FCF TTM 35.7m / Revenue TTM 1.18b)
Net Margin = 5.27% (Net Income TTM 61.9m / Revenue TTM 1.18b)
Gross Margin = 17.96% ((Revenue TTM 1.18b - Cost of Revenue TTM 964.5m) / Revenue TTM)
Gross Margin QoQ = 15.74% (prev 19.08%)
Tobins Q-Ratio = 1.54 (Enterprise Value 1.02b / Total Assets 658.6m)
Interest Expense / Debt = 1.85% (Interest Expense 2.43m / Debt 131.3m)
Taxrate = 25.36% (21.0m / 83.0m)
NOPAT = 63.7m (EBIT 85.4m * (1 - 25.36%))
Current Ratio = 2.08 (Total Current Assets 349.3m / Total Current Liabilities 167.9m)
Debt / Equity = 0.35 (Debt 131.3m / totalStockholderEquity, last quarter 379.9m)
Debt / EBITDA = 1.10 (Net Debt 130.1m / EBITDA 118.7m)
Debt / FCF = 3.64 (Net Debt 130.1m / FCF TTM 35.7m)
Total Stockholder Equity = 375.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.86% (Net Income 61.9m / Total Assets 658.6m)
RoE = 16.51% (Net Income TTM 61.9m / Total Stockholder Equity 375.1m)
RoCE = 20.40% (EBIT 85.4m / Capital Employed (Equity 375.1m + L.T.Debt 43.6m))
RoIC = 11.92% (NOPAT 63.7m / Invested Capital 534.6m)
WACC = 5.08% (E(885.6m)/V(1.02b) * Re(5.63%) + D(131.3m)/V(1.02b) * Rd(1.85%) * (1-Tc(0.25)))
Discount Rate = 5.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 88.37 | Cagr: 0.30%
[DCF] Terminal Value 75.44% ; FCFF base≈35.7m ; Y1≈35.9m ; Y5≈38.0m
[DCF] Fair Price = 50.73 (EV 591.4m - Net Debt 130.1m = Equity 461.3m / Shares 9.09m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 72.61 | EPS CAGR: 12.03% | SUE: -1.17 | # QB: -1
Revenue Correlation: 94.49 | Revenue CAGR: 6.30% | SUE: 0.01 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.62 | Chg30d=-13.47% | Revisions=-25% | Analysts=2
EPS next Quarter (2026-12-31): EPS=1.51 | Chg30d=-7.20% | Revisions=-25% | Analysts=2
EPS current Year (2027-06-30): EPS=6.05 | Chg30d=-7.81% | Revisions=-25% | GrowthEPS=+15.1% | GrowthRev=+1.3%
EPS next Year (2028-06-30): EPS=5.67 | Chg30d=N/A | Revisions=+0% | GrowthEPS=-6.3% | GrowthRev=+3.3%
[Analyst] Revisions Ratio: -50% (up=0, down=3)